Forbes December 5, 2023
Victoria Gray never remembers a moment when she didn’t have sickle cell disease. She was diagnosed with the condition at 3 months of age after she cried so hard during a bath that she was taken to the emergency room. For Gray, who has no close relatives with the disorder, that was the beginning of unrelenting pain, ER visits, hospitalizations and treatments that robbed her of much of her childhood and adult life.
Gray became unable to take care of herself and her family. In hopes that she could improve her life by even 50%, Gray bravely chose to be the first patient to enter a clinical trial using a CRISPR editing drug to treat sickle cell disease. Four and...